AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06638450 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dense Cranial Electroacupuncture Stimulation plus Body Acupuncture (DCEAS+BA)
Description: DCEAS+BA will be conducted for 2 sessions per week for 8 weeks.~For DCEAS, 6 pairs of acupoints are used: Baihui (GV20) and Yintang (EX-HN3), left Sishencong (EX-HN1) and Toulinqi (GB15), right Sishencong (EX-HN1) and Toulinqi (GB15), bilateral Shuaigu (GB8), bilateral Taiyang (EX-HN5), and bilateral Touwei (ST8). For body acupuncture, the following acupoints are used: Shenmen (HT7). Neiguan (PC6), Zhongwan (CV12), Guanyuan (CV4), Zusanli (ST36), Sanyinjiao (SP6), and Taichong (LV3).~Disposable acupuncture needles (0.25 mm in diameter and 25-40 mm in length) are inserted at a depth of 10-30 mm perpendicularly or obliquely into acupoints. Manual manipulation is conducted to evoke a needling sensation. After that, electrical stimulation is delivered on DCEAS, with continuous waves at 2 Hz through an electrical acupuncture stimulation instrument (Hwarto, SDZ-II). The stimulation lasts 30 minutes.
Study NCT06638450 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Minimal Acupuncture Stimulation (MAS)
Description: MAS will be conducted for 2 sessions per week for 8 weeks.~The following 6 acupoints are used: bilateral Tongtian (BL07), bilateral Shousanli (LI10) and bilateral Fuyang (BL59). Electrical stimulation will be only performed on bilateral Tongtian (BL07).
Study NCT05801887 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave device
Description: Extracorporeal shockwave device generates true shock waves which are characterized by a sudden rise in pressure followed by an exponential decay.~This is different from the commercially available shockwave devices in which they use piezoelectric based mechanisms which generate high frequency waves.
Study NCT05801887 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: No ESWT
Description: the osteoblast like cells are not exposed to shockwaves
Study NCT06225349 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with Microencapsulated Magnesium
Description: Volunteers will be provided with the product Microencapsulated Magnesium. For each volunteer, a blood sample from digital puncture will be obtained before (0 hour) and 1, 2, 4, 6, and 8 hours after oral intake of the product, and magnesium levels in plasma will be quantified by ICP-MS.
Study NCT06225349 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with Magnesium Oxide
Description: Volunteers will be provided with the product Magnesium Oxide. For each volunteer, a blood sample from digital puncture will be obtained before (0 hour) and 1, 2, 4, 6, and 8 hours after oral intake of the product, and magnesium levels in plasma will be quantified by ICP-MS.
Study NCT06225349 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with Magnesium Citrate
Description: Volunteers will be provided with the product Magnesium Citrate. For each volunteer, a blood sample from digital puncture will be obtained before (0 hour) and 1, 2, 4, 6, and 8 hours after oral intake of the product, and magnesium levels in plasma will be quantified by ICP-MS.
Study NCT06225349 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with Magnesium Bisglycinate
Description: Volunteers will be provided with the product Magnesium Bisglycinate. For each volunteer, a blood sample from digital puncture will be obtained before (0 hour) and 1, 2, 4, 6, and 8 hours after oral intake of the product, and magnesium levels in plasma will be quantified by ICP-MS.
Study NCT06222684 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music therapy
Description: Women applying for mammography screening will receive music therapy for 5 minutes before the procedure, during the mammography scan and for 5 minutes after the procedure.
Study NCT04710602 — intervention group
Intervention type: PROCEDURE
Intervention: Minimally invasive surgical fixation of unstable rib cage
Description: Minimally invasive and muscle sparing surgical fixation of ribs and/or sternum in an unstable segment of the chest wall (flail chest) with titan plates or medullary nails (MatrixRib Fixation System, DepuySynthes).
Study NCT04710602 — intervention group
Intervention type: PROCEDURE
Intervention: Large incision surgical fixation of unstable rib cage.
Description: Surgical fixation of ribs and/or sternum in an unstable segment of the chest wall (flail chest) with titan plates or medullary nails (MatrixRib Fixation System, DepuySynthes). Large non muscle sparing incision with simultaneous thoracotomy.
Study NCT04744428 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Autism Parent Navigators
Description: The Autism Parent Navigator program consists of six sessions delivered to parents in the home, supporting adjustment to ASD, accessing services, and coparenting support.
Study NCT04744428 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Peer mentoring
Description: Six in-home or telephone sessions, depending on family uptake, providing non-manualized general support as usual from parent peer mentors regarding adjustment to ASD.
Study NCT04923139 — intervention group
Intervention type: DRUG
Intervention: Rivaroxaban (Xarelto, BAY59-7939)
Description: Dosage at the discretion of the treating physician
Study NCT05824858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3537982
Description: Administered orally.
Study NCT05922631 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Airway pressure release ventilation
Description: ventilator parameters were set according to the study protocol, P high: Tidal volume (VT) was set at 6ml/kg of ideal body weight, and plateau pressure (Pplat) was measured. Initial Phigh was set at Pplat, usually 20-32 cmH2O. The APRV end-expiratory flow rate was set at 75% of the peak expiratory flow rate.
Study NCT05922631 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: low tidal volume
Description: The ARDSnet method was used for LTV mechanical ventilation, and the tidal volume was set according to 4-8ml/kg, so that the Pplat was \<30cmH2O
Study NCT06319248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midodrine
Description: Subjects will receive standard of care for sepsis and 10 mg of Midodrine every 8 hours administered orally or enterally (via nasogastric tube)
Study NCT06319248 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Subjects will receive standard of care for sepsis treatment.
Study NCT06227520 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: decellularized dermal matrix
Description: Application of Wound bed
Study NCT06103240 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Lacticaseibacillus rhamnosus LRa05
Description: Bacterial count:100 billion CFUs Take one sachet per day for 4 weeks.
Study NCT06103240 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lacticaseibacillus rhamnosus LRa05
Description: Bacterial count:100 billion CFUs Take one sachet per day for 4 weeks.
Study NCT06565130 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Attention skills training
Description: Attention skills program planned with occupational therapy principles
Study NCT06638697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Free walking
Description: The free walking training program will last 32 weeks. The intensity of the training will be controlled by the scale of perceived exertion (Borg). The training program will have a frequency of two sessions per week, lasting 60 minutes and will be divided into three parts: a) stretching, joint mobility and warm-up; b) main part (according to the objectives of each modality); c) cool-down and final stretching. Both the initial stretching and the final stretching will last five minutes.
Study NCT06638697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nordic walking
Description: The Nordic walking training program will last 32 weeks. The intensity of the training will be controlled by the Borg scale of perceived exertion. The training program will have a frequency of two sessions per week, lasting 60 minutes and will be divided into three parts: a) stretching, joint mobility and warm-up; b) main part (according to the objectives of each modality); c) cool-down and final stretching. Both the initial and final stretching will last five minutes.
Study NCT06638697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dance
Description: The Dance training program will last 32 weeks. The intensity of the training will be controlled by the Borg scale of perceived exertion. The training program will have a frequency of two sessions per week, lasting 60 minutes and will be divided into three parts: a) stretching, joint mobility and warm-up; b) main part (according to the objectives of each modality); c) cool-down and final stretching. Both the initial and final stretching will last five minutes.
Study NCT06638697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical exercise for cognition
Description: The Physical exercise for cognition training program will last 32 weeks. The intensity of the training will be controlled by the Borg scale of perceived exertion. The training program will have a frequency of two sessions per week, lasting 60 minutes and will be divided into three parts: a) stretching, joint mobility and warm-up; b) main part (according to the objectives of each modality); c) cool-down and final stretching. Both the initial and final stretching will last five minutes.
Study NCT06638697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance
Description: The Balance training program will last 32 weeks. The intensity of the training will be controlled by the Borg scale of perceived exertion. The training program will have a frequency of two sessions per week, lasting 60 minutes and will be divided into three parts: a) stretching, joint mobility and warm-up; b) main part (according to the objectives of each modality); c) cool-down and final stretching. Both the initial and final stretching will last five minutes.
Study NCT06638697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aquatic physiotherapy
Description: The Aquatic Physiotherapy training program will last 32 weeks. The intensity of the training will be controlled by the Borg scale of perceived exertion. The training program will have a frequency of two sessions per week, lasting 60 minutes and will be divided into three parts: a) stretching, joint mobility and warm-up; b) main part (according to the objectives of each modality); c) cool-down and final stretching. Both the initial stretching and the final stretching will last five minutes.
Study NCT06638697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multicomponent gymnastics
Description: The Multicomponent Gymnastics training program will last 32 weeks. The intensity of the training will be controlled by the Borg scale of perceived exertion. The training program will have a frequency of two sessions per week, lasting 60 minutes and will be divided into three parts: a) stretching, joint mobility and warm-up; b) main part (according to the objectives of each modality); c) cool-down and final stretching. Both the initial stretching and the final stretching will last five minutes.
Study NCT06638697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Water aerobics
Description: The Water Aerobics training program will last 32 weeks. The intensity of the training will be controlled by the Borg scale of perceived exertion. The training program will have a frequency of two sessions per week, lasting 60 minutes and will be divided into three parts: a) stretching, joint mobility and warm-up; b) main part (according to the objectives of each modality); c) cool-down and final stretching. Both the initial stretching and the final stretching will last five minutes.
Study NCT06638697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hydroposture
Description: The Hydroposture training program will last 32 weeks. The intensity of the training will be controlled by the Borg scale of perceived exertion. The training program will have a frequency of two sessions per week, lasting 60 minutes and will be divided into three parts: a) stretching, joint mobility and warm-up; b) main part (according to the objectives of each modality); c) cool-down and final stretching. Both the initial stretching and the final stretching will last five minutes.
Study NCT06638697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: deep water walking
Description: The deep water walking training program will last 32 weeks. The intensity of the training will be controlled by the Borg scale of perceived exertion. The training program will have a frequency of two sessions per week, lasting 60 minutes and will be divided into three parts: a) stretching, joint mobility and warm-up; b) main part (according to the objectives of each modality); c) cool-down and final stretching. Both the initial stretching and the final stretching will last five minutes.
Study NCT06638697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Weight training
Description: The weight training program will last 32 weeks. The intensity of the training will be controlled by the Borg scale of perceived exertion. The training program will have a frequency of two sessions per week, lasting 60 minutes and will be divided into three parts: a) stretching, joint mobility and warm-up; b) main part (according to the objectives of each modality); c) cool-down and final stretching. Both the initial stretching and the final stretching will last five minutes.
Study NCT06638697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mat pilates
Description: The MAt pilates program will last 32 weeks. The intensity of the training will be controlled by the Borg scale of perceived exertion. The training program will have a frequency of two sessions per week, lasting 60 minutes and will be divided into three parts: a) stretching, joint mobility and warm-up; b) main part (according to the objectives of each modality); c) cool-down and final stretching. Both the initial stretching and the final stretching will last five minutes.
Study NCT05488483 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Multispectral Optoacoustic Tomography Imaging
Description: Each participants will undergo MSOT imaging of the suspicious breast tumor detected with ultrasound imaging and any additional lesion present in either breast before undergoing ultrasound-guided breast biopsy as the standard of care. Melanoma participants with pathologically confirmed ITM will undergo MSOT imaging following physical exam and biopsy. Melanoma patients receiving immunotherapy will undergo MSOT imaging prior to and following immunotherapy.
Study NCT05218707 — intervention group
Intervention type: OTHER
Intervention: GUEDEL Airway
Description: GUEDEL Airway of size '000,00,0,' and '1' will be used.
Study NCT05389072 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: control contact lens
Description: control CRT lens
Study NCT04886531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neratinib
Description: 120mg for 7 days; 160mg for 7 days ; 240mg for 7 days. 240 mg (up to a maximum of 24 weeks) orally daily\*.
Study NCT04886531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole (L) or Anastrozole (A)
Description: L: (2.5 mg) OR A: (1 mg) orally daily (up to a maximum of 24 weeks)\*
Study NCT04886531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: All Arms 8mg/kg loading dose followed by 6mg/kg every 3 weeks administered every 3 weeks by IV starting wk 4. Trastuzumab biosimilars may be used per institutional guidelines.
Study NCT06365463 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Description: The training will last for 6 weeks, with two 60-minute sessions of balance and mobility training per week. Two consecutive groups will participate.
Study NCT05562934 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Experimental drug
Description: SC injection
Study NCT05562934 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: SC injection
Study NCT06303427 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modified constraint-induced movement therapy
Description: The unaffected arm will be restricted by using an upper extremity sling that will strap to the child's trunk with a distal end fastened to prevent the movement of the unaffected limb.~The modified constraint-induced movement therapy will include these exercises.~1. Playing with ball.~2. Playing with modeling clay.~3. Playing with LEGOS (building towers or different shapes from the toy bricks).~4. Tearing a paper towel from a roll.~5. Holding and eating biscuits.~6. Eating with a spoon.~7. Drinking from a glass.~8. Combing hair.~9. Brushing teeth.~10. Making bubbles using a bubble blower.~11. Pulling a toy.~12. Placing a hat or piece of cloth on the head.~13. Applying lotion to the trained caregiver.
Study NCT06303427 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Description: The participants in this group will first receive a 20-minute session of electrical stimulation (on time of 10 s, off time of 30 s, pulse rate of 35 Hz, the pulse width of 300 µs).
Study NCT05473715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aflibercept(BAY86-5321, Eylea)
Description: 2mg, intravitreal (IVT) injection
Study NCT05473715 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aflibercept(BAY86-5321, Eylea)
Description: 2mg, intravitreal (IVT) injection
Study NCT06409260 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Acceleromyography (AMG)
Description: Philips IntelliVue NMT Module
Study NCT05465941 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy
Study NCT05465941 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegylated SN-38 Conjugate PLX038
Description: Given IV
Study NCT05465941 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT06409260 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Electromyography (EMG)
Description: Senzime TetraGraph
Study NCT06637579 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: universal exercise unit therapy with task oriented strength training
Description: Leg press, Sit to stand, Half knee rise, Lateral step up, Forward step up.
Study NCT06637579 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Task-oriented training for gross motor functioning
Description: Standing transfer (hip abduction/adduction), Stair climbing (hip extension, calf raise), Walking and gait training, Reaching and grasping activities.
Study NCT06642025 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAR-T Cell Injection
Description: Conditioning chemotherapy: Lymphodepletion regimen consisting of fludarabine 25 mg/m2/day and cyclophosphamide 250 mg/m2/day for 3 consecutive days, administered 48 hours before intraperitoneal infusion.~On the day of administration, premedication with 500mg of acetaminophen orally and 20mg of promethazine intramuscularly or intravenously (or other non-steroidal anti-inflammatory drugs and antihistamines) should be given 30 minutes before intraperitoneal infusion.~The therapeutic dose of CAR-T cells is defined as intravenous injection of 1.0E6 CAR-T cells/kg as the initial standard dosage.
Study NCT06637657 — intervention group
Intervention type: OTHER
Intervention: No intervention (observational study)
Description: No intervention, only guideline implementation (observational study)
Study NCT06638528 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walking apnea at High Lung Volume
Description: Walking apnea at High Lung Volume Participants walk at 6 km/h (10% slope) on treadmill for 6 minutes. Participants in the experimental group will perform intermittent apneas at high lung volume with a density of 5 seconds, followed by a normal breath of 5 seconds until completing the 6 minutes)
Study NCT06638528 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Walking normal breathing
Description: Participants walk at 6 km/h (10% slope) on treadmill for 6 minutes. Participants in the control group will remain breathing normally for these 6 minutes.
Study NCT06644703 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Description: The pulpotomy area was irrigated with 2 °C saline solution for 5 minutes in cryotherapy group.
Study NCT06644365 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupresure mat
Description: The Premenstrual Syndrome Scale will be applied and the scale results will be evaluated. Participants who score 132 and above on the scale will be considered to be experiencing PMS. The intervention will be made in the second phase of the study.This practice will continue for three menstrual cycles.
Study NCT06644365 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Basic mat
Description: The Premenstrual Syndrome Scale will be applied and the scale results will be evaluated. Participants who score 132 and above on the scale will be considered to be experiencing PMS. The intervention will be made in the second phase of the study.Participants in this group will also be sent a reminder message similar to the intervention group. This practice will continue for three menstrual cycles.
Study NCT06645431 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Water Intake
Description: Previous studies have not observed blood glucose with adequate vs. low water intake in a free-living situation. The use of continuous glucose monitors allows this.
Study NCT05097612 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Placebo LiftSuit Exoskeleton
Description: The LiftSuit is a soft passive wearable device that is designed to support the hip and back muscles during forward leaning and lifting. It exerts it function through Elastic Energy Storages (EES). In this condition the EES are removed from the device to create a placebo device.